Author:
Albarazanji Kamal,Nawrocki Andrea R.,Gao Bin,Wang Xiaoli,Wang Yixin,Xiao Yong-Fu
Abstract
AbstractMeal ingestion elicits a variety of neuronal, physiological and hormonal responses that differ in healthy, obese or diabetic individuals. The mixed meal tolerance test (MMTT) is a well-established method to evaluate pancreatic β-cell reserve and glucose homeostasis in both preclinical and clinical research in response to calorically defined meal. Nonhuman primates (NHPs) are highly valuable for diabetic research as they can naturally develop type 2 diabetes mellitus (T2DM) in a way similar to the onset and progression of human T2DM. The purpose of this study was to investigate the reproducibility and effects of a MMTT containing acetaminophen on plasma glucose, insulin, C-peptide, incretin hormones, lipids, acetaminophen appearance (a surrogate marker for gastric emptying) in 16 conscious obese cynomolgus monkeys (Macaca fascicularis). Plasma insulin, C-peptide, TG, aGLP-1, tGIP, PYY and acetaminophen significantly increased after meal/acetaminophen administration. A subsequent study in 6 animals showed that the changes of plasma glucose, insulin, C-peptide, lipids and acetaminophen were reproducible. There were no significant differences in responses to the MMTT among the obese NHPs with (n = 11) or without (n = 5) hyperglycemia. Our results demonstrate that mixed meal administration induces significant secretion of several incretins which are critical for maintaining glucose homeostasis. In addition, the responses to the MMTTs are reproducible in NHPs, which is important when the MMTT is used for evaluating post-meal glucose homeostasis in research.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Brodovicz, K. G. et al. Postprandial metabolic responses to mixed versus liquid meal tests in healthy men and men with type 2 diabetes. Diabetes Res. Clin. Pract. 94(3), 449–455 (2011).
2. Greenbaum, C. et al. Mixed-meal tolerance test versus glucagon stimulation test for assessment of β-cell function in therapeutic trials in Type 1 diabetes. Diabetes Care 31(10), 1966–1971 (2008).
3. Mojto, V., Rausova, Z., Chrenova, J. & Dedik, L. Short-term glucagon stimulation test of C-peptide effect on glucose utilization in patients with type 1 diabetes mellitus. Med. Biol. Eng. Comput. 53(12), 1361–1369 (2015).
4. Fujioka, Y. et al. Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity. J. Diabetes Investig. 9(2), 274–278 (2018).
5. Scheen, A. J., Castillo, M. J. & Lefèbvre, P. J. Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: Methodological aspects and clinical applications. Diabetes Metab. 22(6), 397–406 (1996).
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献